Cargando…

Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic

INTRODUCTION: Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at the time of COVID-19 pandemic. The objective of this study was to assess the long-term effectiveness and safety of DM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Maria, Campanati, Anna, Giunta, Alessandro, Calianno, Gianluca, Bianchi, Luca, Diotallevi, Federico, Offidani, Anna Maria, Fargnoli, Maria Concetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805130/ https://www.ncbi.nlm.nih.gov/pubmed/35103934 http://dx.doi.org/10.1007/s13555-022-00684-3

Ejemplares similares

Treatment of severe psoriasis during pregnancy and breastfeeding: A therapeutic challenging case
por: Esposito, Maria, et al.
Publicado: (2021)

New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate
por: Matteo, Paolinelli, et al.
Publicado: (2022)

Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities
por: Campanati, Anna, et al.
Publicado: (2022)

Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
por: Campanati, Anna, et al.
Publicado: (2021)

Mesenchymal Stem Cells and Psoriasis: Systematic Review
por: Diotallevi, Federico, et al.
Publicado: (2022)

Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption
por: Campanati, Anna, et al.
Publicado: (2019)

Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real‐life multicenter prospective observational cohort study
por: Campanati, Anna, et al.
Publicado: (2021)

Saliva and Oral Diseases
por: Martina, Emanuela, et al.
Publicado: (2020)

Satisfaction and attitudes toward systemic treatments for psoriasis: A cross‐sectional study
por: Esposito, Maria, et al.
Publicado: (2021)

Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
por: Campanati, Anna, et al.
Publicado: (2023)

Dimethyl fumarate treatment for psoriasis in a real‐life setting: A multicentric retrospective study
por: Corazza, Monica, et al.
Publicado: (2021)

Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy
por: Diotallevi, Federico, et al.
Publicado: (2021)

Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
por: Martina, Emanuela, et al.
Publicado: (2021)

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study
por: GNESOTTO, Laura, et al.
Publicado: (2023)

miRNAs, Mesenchymal Stromal Cells and Major Neoplastic and Inflammatory Skin Diseases: A Page Being Written: A Systematic Review
por: Di Vincenzo, Mariangela, et al.
Publicado: (2023)

The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway
por: Campione, Elena, et al.
Publicado: (2022)

Latest combination therapies in psoriasis: Narrative review of the literature
por: Diotallevi, Federico, et al.
Publicado: (2022)

Drug-Repurposing Strategy for Dimethyl Fumarate
por: Giunta, Salvatore, et al.
Publicado: (2023)

Should we be concerned about gastrointestinal‐related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real‐life study
por: Diotallevi, Federico, et al.
Publicado: (2022)

Mechanisms of Sensitivity and Resistance of Primary Effusion Lymphoma to Dimethyl Fumarate (DMF)
por: Gonnella, Roberta, et al.
Publicado: (2022)

The CANOVA Study Real-World Evidence of Biologic Treatments in Moderate-Severe Psoriasis in Italy: A Gender Perspective
por: Colombo, Delia, et al.
Publicado: (2022)

Fluorescence‐guided surgery for non‐melanoma and melanoma skin cancer: Case series and a brief review of the literature
por: Ivan, Bobyr, et al.
Publicado: (2021)

Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study
por: Pellegrini, Cristina, et al.
Publicado: (2022)

Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
por: Fargnoli, Maria Concetta
Publicado: (2019)

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus
por: Burlando, Martina, et al.
Publicado: (2022)

Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice
por: Babino, Graziella, et al.
Publicado: (2016)

Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis
por: Malara, Giovanna, et al.
Publicado: (2021)

Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience
por: Rosés Gibert, Pau, et al.
Publicado: (2022)

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management
por: Cannizzaro, Maria Vittoria, et al.
Publicado: (2017)

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
por: Giunta, Alessandro, et al.
Publicado: (2017)

Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives
por: Diotallevi, Federico, et al.
Publicado: (2022)

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients
por: Burlando, Martina, et al.
Publicado: (2022)

Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study
por: Pellacani, Giovanni, et al.
Publicado: (2022)

Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data
por: Landeck, Lilla, et al.
Publicado: (2018)

Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosis
por: Moreira Ferreira, Vanessa F, et al.
Publicado: (2021)

InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study
por: Diotallevi, Federico, et al.
Publicado: (2023)

Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence
por: Alroughani, Raed, et al.
Publicado: (2017)

Patients’ demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis
por: Scala, Emanuele, et al.
Publicado: (2020)

Switch of psoriasis therapy from a fumaric acid ester mixture to dimethyl fumarate monotherapy: Results of a prospective study
por: Falkvoll, Sandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_74np8cifoo5rj5tdpv5najh33r